Case File
efta-01452905DOJ Data Set 10OtherEFTA01452905
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01452905
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
(Embedded image moved to file: pic27285.gif)
Nam Gupta
Managing Director
Deutsche Bank AG, Filiale London
Deutsche Asset & wealth Management
105/108 old Broad st (Pinners Hall), Ec2N lEN London, united Kingdom
Any proposed ideas are being delivered to you by the DeAWM Key Client Partners
("KcP") London desk for discussion purposes only, and do not create any
legally binding obligation on the part of Deutsche Bank AG and / or its
affiliates ("OS"). These ideas are for the consideration of the intended
recipients of this mail only. The KCP London desk does not provide investment
advice. All intended recipients are Professional investors (as defined by
MiFID), who understand the strategy, characteristics and risks associated with
any ideas proposed herein and will be able to evaluate it independently. All
trades on proposed ideas shall be subject to the relevant internal approvals
prior to execution.
(Embedded image moved to file: pic10988.gif)
Forwarded by Tazia Smith/db/dbcom on 03/07/2014 01:18 PM
From:
Jeffrey Epstein <[email protected]
To:
Tazia Smith/
01/17/2014 11:15 AM
Subject:
Re: Trade Idea: Long 3-Month USDCAD KI Call Spread - 1.10 with a 1.13 sold call knocking-in
only if USDCAD
trades to 1.17 [I]
i like it
.. size ?
On Fri, Jan 17, 2014 at 11:48 AM, Tazia Smith <[email protected]> wrote:
classification: For internal use only
Jeffrey -
Our US FX traders agree/like Nav's call here. The 3-month 1.10/1.13 USDCAD,
1.17 knock-in call spread (where that 1.13 short call only exists if USDCAD
goes to 1.17 during the life of the trade) described below is currently
offered —1.1% (Source: DB FX sales, 1/17/14). Please see the investment
thesis below and let us know your thoughts.
Best,
Tazia
Indicative levels only. subject to market movement. Source: DB Key Client
Partners London, as of 1/17/14.
Forwarded by Tazia Smith
on 01/17/2014 10:35 AM
From: Nav Gupta
To:
Date: 01/17/2014 07:35 AM
CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0 110220
CONFIDENTIAL
SDNY_GM_00256404
EFTA01452905
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.